메뉴 건너뛰기




Volumn 9, Issue 2, 2009, Pages 118-126

Multiple sclerosis

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; MULTIPLE SCLEROSIS;

EID: 65349188867     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/jnnp.2008.171132     Document Type: Article
Times cited : (33)

References (10)
  • 1
    • 65349160910 scopus 로고    scopus 로고
    • ABN Guidelines for 2007 (Updated from 2001)
    • Association of British Neurologists, London: Association of British Neurologists
    • Association of British Neurologists. ABN Guidelines for 2007 (Updated from 2001). Treatment of multiple sclerosis with β-interferon and glatiramer acetate. London: Association of British Neurologists, 2007
    • (2007) Treatment of multiple sclerosis with β-interferon and glatiramer acetate
  • 3
    • 54149084585 scopus 로고    scopus 로고
    • Multiple sclerosis
    • Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17
    • (2008) Lancet , vol.372 , pp. 1502-1517
    • Compston, A.1    Coles, A.2
  • 4
    • 54049140996 scopus 로고    scopus 로고
    • Neuromyelitis optica: Diagnosis, pathogenesis, and treatment
    • Cree B. Neuromyelitis optica: diagnosis, pathogenesis, and treatment. Curr Neurol Neurosci Rep 2008;8:427-33.
    • (2008) Curr Neurol Neurosci Rep , vol.8 , pp. 427-433
    • Cree, B.1
  • 5
    • 44949141642 scopus 로고    scopus 로고
    • Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
    • CD005278
    • Clerico M, Faggiano F, Palace J, et al. Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database Syst Rev 008;(2):CD005278
    • Cochrane Database Syst Rev 008
    • Clerico, M.1    Faggiano, F.2    Palace, J.3
  • 6
    • 54049087015 scopus 로고    scopus 로고
    • Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    • Goodin DS, Cohen BA, O'Connor P, et al, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;71:766-73.
    • (2008) Neurology , vol.71 , pp. 766-773
    • Goodin, D.S.1    Cohen, B.A.2    O'Connor, P.3
  • 7
    • 34547661898 scopus 로고    scopus 로고
    • Neutralising antibodies to interferon beta in multiple sclerosis: Expert panel report
    • Hartung HP, Polman C, Bertolotto A, et al. Neutralising antibodies to interferon beta in multiple sclerosis: expert panel report. J Neurol 2007;254:827-37.
    • (2007) J Neurol , vol.254 , pp. 827-837
    • Hartung, H.P.1    Polman, C.2    Bertolotto, A.3
  • 8
    • 5444248509 scopus 로고    scopus 로고
    • Multiple sclerosis. Management of multiple sclerosis in primary and secondary care
    • NICE Guidelines, 8 November, Developed by the National Collaborating Centre for Chronic Conditions
    • NICE Guidelines. Multiple sclerosis. Management of multiple sclerosis in primary and secondary care. Clinical Guideline 8 November 2003. Developed by the National Collaborating Centre for Chronic Conditions.
    • (2003) Clinical Guideline
  • 9
    • 28544436950 scopus 로고    scopus 로고
    • Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''
    • Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''. Ann Neurol 2005;58:840-6.
    • (2005) Ann Neurol , vol.58 , pp. 840-846
    • Polman, C.H.1    Reingold, S.C.2    Edan, G.3
  • 10
    • 39449121111 scopus 로고    scopus 로고
    • Acute disseminated encephalomyelitis: Current understanding and controversies
    • Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 2008;28:84-94.
    • (2008) Semin Neurol , vol.28 , pp. 84-94
    • Young, N.P.1    Weinshenker, B.G.2    Lucchinetti, C.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.